EyewireTV

04.29.2026

Eyewire TV April 29, 2026 thumbnail

04.29.2026

story 1 429 thumbnail

Brent Saunders, Bausch + Lomb

story 2 429 thumbnail

Julie Brewer, Alcon

story 3 429 thumbnail

Mark Baum, Harrow

Watch Latest Episode

Stocks

Sort by:

4D Molecular Therapeutics $9.25 4.23%

AbbVie $207.53 -1.80%

Alcon $74.50 -0.49%

Aldeyra Therapeutics $1.56 2.30%

Annexon, Inc. $5.82 -0.94%

Apellis Pharmaceuticals $40.96 0.01%

Astellas Pharma $14.30 0.70%

Bausch + Lomb $16.22 1.98%

Bausch Health Companies $5.68 -0.70%

Bayer $11.17 5.98%

Biogen $187.01 -1.20%

EyePoint Pharmaceuticals $13.33 0.98%

Glaukos $142.43 -0.86%

Harrow $40.92 0.95%

InMed Pharmaceuticals $0.77 6.94%

Iridex Corporation $1.05 1.46%

Johnson & Johnson $228.45 -0.61%

Kala Bio $0.11 3.33%

Kiora Pharmaceuticals $2.41 2.55%

Krystal Biotech $263.97 0.65%

Lensar $5.67 8.41%

LENZ Therapeutics $8.80 -2.06%

Lineage Cell Therapeutics $1.55 2.32%

MeiraGTx Holdings $9.41 2.01%

Merck & Company $112.42 2.97%

National Vision Holdings $23.52 1.29%

NovaBay Pharmaceuticals, Inc. $1.95 22.64%

Novartis $146.95 -0.61%

Ocugen $1.79 3.47%

Ocular Therapeutix $9.42 0.48%

Oculis $27.28 -0.75%

Okyo Pharma $1.72 10.26%

Omeros Corp. $15.01 2.77%

Opus Genetics $5.18 1.27%

Outlook Therapeutics $0.26 3.96%

Regeneron $702.47 -0.65%

Regenxbio $9.18 2.34%

Roche $50.88 0.89%

RxSight $7.34 3.75%

Sight Sciences $4.37 6.85%

STAAR Surgical Company $26.95 2.22%

Takeda Pharmaceutical Company $16.65 -0.21%

Tarsus Pharmaceuticals $63.31 -0.47%

The Cooper Companies $62.43 -0.75%

Viatris $15.03 0.57%

Viridian Therapeutics, Inc. $10.05 -1.62%

View More Stocks

View More Stocks

Cataract

View More

Biogen Enters GA Treatment Market After Major Acquisition

Eyetube

Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices

ESCRS Heritage Lecture thumbnail

ESCRS Heritage Lecture

Robert H. Osher, MD

Eyetube

Brazil Osher Lecture thumbnail

Brazil Osher Lecture

Iqbal Ike K. Ahmed, MD, FRCSC

Eyetube

The Slit Lamp Reinvented for the 21st Century

The Elara 900 brings the finest details into sharp focus while streamlining workflow and enhancing ergonomics.

Iqbal (Ike) K. Ahmed, MD, FRCSC; Gerd U. Auffarth, MD, PhD, FEBO; David Goldblum, MD; Maria Kugelberg, MD, PhD; Sunil Mamtora, MBBS; Filomena Ribeiro MD, PhD, FEBO

Cataract and Refractive Surgery Today

Interview with ASCRS Executive Director Steve Speares

Eyetube

2024 Glaucoma Pipeline

Cataract and Refractive Surgery Today

05.01.2026

Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal

Eyewire News

04.23.2026

OpenAI Launches ChatGPT for Clinicians with New Healthcare-Focused Capabilities

Eyewire News

04.20.2026

BVI Secures CE Mark for Virtuoso Surgical Platform

Eyewire News

04.20.2026

EssilorLuxottica Partners with TFOS to Advance Global Standards in Ocular Surface Health

Eyewire News

View More

Refractive

View More

Glaukos Issued J-Code for Recently Launched Epioxa

Eyetube

Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting. Learn more about your ad choices. Visit megaphone.fm/adchoices

Trends in the Surgical Management of Presbyopia

What we have learned in practice.

Luke Rebenitsch, MD, and Lukas Mees, MD

Cataract and Refractive Surgery Today

Interview with ASCRS Executive Director Steve Speares

Eyetube

The Life-Altering Burden of Keratoconus

Early intervention and thoughtful surgical planning can restore functional vision, increase independence, and improve quality of life in patients with keratoconus.

Brooke Messer, OD, FAAO, FSLS

Cataract and Refractive Surgery Today

Biogen Enters GA Treatment Market After Major Acquisition

Eyetube

Alcon and Lensar Call Off Merger

Eyetube

05.01.2026

Sydnexis to Present New Subgroup Data from Phase 3 STAR Trial of SYD-101 at ARVO 2026

Eyewire News

05.01.2026

Early Screening and Outdoor Activity Key to Tackling Childhood Myopia, Italian Study Finds

Eyewire News

04.23.2026

Theialife Appoints Thomas Ruggia as President and CEO

Eyewire News

04.23.2026

OpenAI Launches ChatGPT for Clinicians with New Healthcare-Focused Capabilities

Eyewire News

View More

Stay Updated

Sign up for Eyewire News and EyewireTV e‑newsletters to stay up to date on news in eye care!

Subscribe

Retina

View More

Suprachoroidal Silicone Oil thumbnail

Suprachoroidal Silicone Oil

Eyetube

Stickler Syndrome thumbnail

Stickler Syndrome

Eyetube

Scleral Buckling thumbnail

Scleral Buckling

Eyetube

A Rare Case of Choroidal Vitiligo image

A Rare Case of Choroidal Vitiligo

Recognize this uncommon sign of varicella-zoster reactivation.

Tina Tang, MD, and Nauman Chaudhry, MD

Retina Today

Using Category III Codes image

Using Category III Codes

Five tips to help improve accuracy, payment, and compliance.

Matthew Baugh, MHA, COT, OCS, OCSR

Retina Today

OR Tech Update: 3D Displays, AI, and Robotics image

OR Tech Update: 3D Displays, AI, and Robotics

New visualization tools are expanding what’s possible in the OR.

Kareena Chawla, BS; Jayanth Sridhar, MD; and Prashant D. Tailor, MD

Retina Today

05.01.2026

Astellas Showcases New Geographic Atrophy Research at ARVO 2026

Eyewire News

05.01.2026

EyePoint Outlines Poster Presentations at the ARVO 2026

Eyewire News

05.01.2026

Oculis Showcases Pipeline Innovations Ahead of Key Data Readouts at ARVO 2026

Eyewire News

04.30.2026

Study Links Diabetic Retinopathy Severity to Higher Mortality Risk

Eyewire News

View More

Glaucoma

View More

Using Imaging to Understand the Causes and Sequelae of Hypotony

A- and B-scan ultrasound, ultrasound biomicroscopy, and OCT can be crucial for diagnosis and management.

Poojitha Balakrishnan, MD, MPH, PhD, and Jithin Yohannan, MD, MPH

Glaucoma Today

Key Takeaways Hypotony is a significant complication of glaucoma surgery, frequently observed following filtering surgery. Identifying the causes and sequelae of hypotony can be a challenge with slit-lamp examinations and indirect ophthalmoscopy alone. Imaging modalities such as OCT, A- and B-scan ultrasound, and ultrasound biomicroscopy may be valuable complementary tools for diagnosing and managing hypotony. Hypotony (IOP < 5–6 mm Hg) may be a significant complication of glaucoma surgery and is most frequently observed during the postoperative period, particularly following filtering surgery. Although the condition is often visually insignificant and/or transient, persistent and visually significant hypotony can lead to adverse outcomes. Clinically significant hypotony may induce neurosensory retinal and structural alterations, potentially resulting in irreversible visual impairment.1,2

MIGS April thumbnail

The Importance (and Unimportance) of ECL in IG

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Manjool Shah, MD

Eyetube

Glaukos Issued J-Code for Recently Launched Epioxa

Eyetube

Breaking News from the ASCRS Meeting in Washington DC

Eyetube

Tips and Tricks for Acing USMLE Step 3

A practical, no-nonsense guide for the busy resident.

Fatma F. Shakarchi, MD, MSc

Glaucoma Today

Interventional Glaucoma: iTrack Canaloplasty and iDose thumbnail

Interventional Glaucoma: iTrack Canaloplasty and iDose

I. Paul Singh, MD

Eyetube

05.01.2026

Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal

Eyewire News

04.29.2026

Zeiss to Showcase AI-Driven Retinal Research and Imaging Advances at ARVO 2026

Eyewire News

04.29.2026

ViaLase to Present New Scientific Findings at ARVO 2026

Eyewire News

04.28.2026

Teledyne Technologies to Showcase its OCT Imaging Solutions at ARVO

Eyewire News

View More

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

Optometry

View More

Presbyopia: The Future Is Here image

Presbyopia: The Future Is Here

New treatment options are helping us meet patient needs better than ever before.

Neena James, OD

Modern Optometry

Presbyopia is universal; if we live long enough, we will all experience it. Researchers reported that 1.8 billion people were presbyopic in 2015 and that, by 2030, this number will reach 2.1 billion.1 The need for more treatment options is vast, and innovation in this field is welcome. Growth is the name of the game; think of how many patients who rely on readers alone have never had a comprehensive eye examination. That makes presbyopia not only a treatment opportunity but also a gateway to preventative eye care and broader eye health education. To optometrists, presbyopia feels routine. We know there is nothing wrong, and we know it is inevitable. For many patients, however, struggling to see up close is life-changing. It can be scary, frustrating, and often embarrassing, especially in a world that depends on smartphones. Presbyopia has been shown to cause more symptoms and reduce quality of life more than hypertension, glaucoma, and macular degeneration combined.2 Even in its earliest stages, presbyopia can interfere with daily routines. Our role, and the role of our staff, is not only to offer solutions but also to show compassion and help patients feel understood and seen (pun intended).

Navigating a Winding Path image

Navigating a Winding Path

Make your journey your own and be prepared to handle what life may throw at you.

Cecelia Koetting, OD, FAAO, Dipl ABO

Modern Optometry

Biogen Enters GA Treatment Market After Major Acquisition

Eyetube

Adopting Epi-On CXL for KC thumbnail

Adopting Epi-On CXL for KC

Joseph J. Allen, OD, FAAO, Dipl ABO

Eyetube

Glaukos Issued J-Code for Recently Launched Epioxa

Eyetube

More than 3 Million Bottles of Eye Drops Recalled

Eyetube

05.01.2026

Sydnexis to Present New Subgroup Data from Phase 3 STAR Trial of SYD-101 at ARVO 2026

Eyewire News

05.01.2026

Early Screening and Outdoor Activity Key to Tackling Childhood Myopia, Italian Study Finds

Eyewire News

05.01.2026

International Congress of Scleral Contacts: A Chance to Advance Your Skills

Eyewire News

05.01.2026

Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal

Eyewire News

View More

Business

View More

Using Category III Codes image

Using Category III Codes

Five tips to help improve accuracy, payment, and compliance.

Matthew Baugh, MHA, COT, OCS, OCSR

Retina Today

Accurate coding for emerging retinal technologies requires more than familiarity with the standard American Medical Association (AMA) Current Procedural Terminology (CPT) Category I and Healthcare Common Procedure Coding System (HCPCS) codes; it also requires understanding CPT Category III codes. These temporary tracking codes, or “T” codes, are increasingly common in retina as innovation accelerates, yet they remain a frequent source of confusion, denials, and compliance risk. CPT Category III codes consist of four numeric characters followed by the letter “T.” Although they are valid CPT codes, they do not have assigned relative value units (RVUs) or national Medicare payment rates. As a result, coverage and carrier pricing for reimbursement are determined by the Medicare Administrative Contractor (MAC) or the individual payer. The following five practical tips outline how retina practices can use CPT Category III codes correctly to improve payer outcomes and position emerging services for future CPT Category I promotion. TIP NO. 1: DON’T DEFAULT TO PATIENT PAY A common misconception is that Category III codes are inherently noncovered and should automatically be billed to the patient. However, Category III status does not always mean investigational or noncovered. Rather, when a procedure is best described with a Category III code, it should be billed as such on the claim. Coverage decisions are based on medical necessity and payer policy—not the code category alone.

Glaukos Issued J-Code for Recently Launched Epioxa

Eyetube

Retina Coding Crash Course image

Retina Coding Crash Course

This outline will help you begin to master this necessary skill.

Justin C. Muste, MD, and Omesh P. Gupta, MD, MBA

Retina Today

Study: Metformin May Lower AMD Progression

Eyetube

More than 3 Million Bottles of Eye Drops Recalled

Eyetube

Alcon and Lensar Call Off Merger

Eyetube

05.01.2026

Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal

Eyewire News

04.30.2026

NAMSA and Lexitas Forge Strategic Partnership to Advance Ophthalmic Device Development

Eyewire News

04.27.2026

Heidelberg Engineering Announces Plans to Showcase Innovations at ARVO 2026

Eyewire News

04.23.2026

Theialife Appoints Thomas Ruggia as President and CEO

Eyewire News

View More